Structures by: Gdaniec M.
Total: 209
Cholic acid--quinoxaline (2/1)
2(C24H40O5),(C8H6N2)
Acta Crystallographica Section E (2008) 64, 6 o1138
a=12.2799(5)Å b=7.8968(3)Å c=14.2831(5)Å
α=90.00° β=104.653(4)° γ=90.00°
Quinoxaline--3-aminophenol--water (2/1/2)
2(C8H6N2),C6H7NO,2(H2O)
Acta Crystallographica Section E (2008) 64, 5 o895
a=15.2951(10)Å b=7.1383(4)Å c=20.1614(14)Å
α=90.00° β=110.775(8)° γ=90.00°
2-(5-Bromo-2-methyl-4-nitroimidazol-1-yl)-1-(2-chlorophenyl)ethanone
C12H9BrClN3O3
Acta Crystallographica Section E (2007) 63, 4 o1669-o1671
a=8.4929(8)Å b=23.8609(13)Å c=7.5005(5)Å
α=90.00° β=120.190(7)° γ=90.00°
2,3,4,5,6-Pentafluoroaniline
C6H2F5N
Acta Crystallographica Section E (2007) 63, 6 o2954-o2954
a=7.591(2)Å b=13.311(2)Å c=6.4023(14)Å
α=90.00° β=110.90(2)° γ=90.00°
N-Amidinio-3,5,5-trimethyl-2-pyrazoline-1-carboxamidine chloride
C8H17N6,Cl
Acta Crystallographica Section E (2007) 63, 1 o124-o125
a=8.5463(7)Å b=10.5588(9)Å c=13.2894(11)Å
α=90.00° β=95.150(7)° γ=90.00°
Phenazine--2,6-dihydroxybenzoic acid (1/1)
C12H8N2,C7H6O4
Acta Crystallographica Section E (2007) 63, 2 o707-o709
a=16.5921(18)Å b=7.4480(7)Å c=25.297(2)Å
α=90.00° β=103.57(2)° γ=90.00°
Lagoden
Na,C20H33O6,0.5C3H7NO,2H2O
Acta Crystallographica Section C (2009) 65, 10 m367-m370
a=10.7614(2)Å b=31.0703(5)Å c=14.7131(3)Å
α=90.00° β=110.948(2)° γ=90.00°
Γ-resorcylic acid
C7H6O4
Acta Crystallographica Section C (1994) 50, 10 1622-1626
a=14.174(3)Å b=12.132(2)Å c=3.8280(10)Å
α=90.00° β=90.00° γ=90.00°
Pyridinium 2,6-Dihydroxybenzoate
C5H6N1,C7H5O41
Acta Crystallographica Section C (1994) 50, 10 1622-1626
a=8.206(2)Å b=10.182(2)Å c=13.313(3)Å
α=90.00° β=100.94(3)° γ=90.00°
Γ-resorcylic acid hydrate
C7H6O4,H2O
Acta Crystallographica Section C (1994) 50, 10 1622-1626
a=6.7780(10)Å b=9.4110(10)Å c=11.890(2)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-6-(1-imidazolylmethyl)-4-(3,5,5-trimethyl-2-pyrazolin-1-yl)- 1,3,5-triazine
C13H18N8
Acta Crystallographica Section C (2003) 59, 12 o696-o699
a=8.2493(7)Å b=9.4564(7)Å c=9.7050(8)Å
α=93.221(5)° β=105.342(5)° γ=106.191(6)°
2-Amino-6-(1-benzimidazolylmethyl)-4-(3,5,5-trimethyl-2-pyrazolin-1-yl)- 1,3,5-triazine hemihydrate
C17H20N8,0.5H2O
Acta Crystallographica Section C (2003) 59, 12 o696-o699
a=22.5030(14)Å b=8.3217(6)Å c=18.4269(12)Å
α=90.00° β=94.667(5)° γ=90.00°
Phenazine β-polymorph
C12H8N2
Acta Crystallographica Section C (2002) 58, 3 o181-o182
a=11.6418(12)Å b=11.5449(11)Å c=6.8981(7)Å
α=90° β=99.476(10)° γ=90°
N,N'-bis(2-pyridyl)benzene-1,4-diamine 2,5-dihydroxy-1,4-benzoquinone (1/1)
C16H14N4,C6H4O4
Acta Crystallographica Section C (2002) 58, 12 o735-o738
a=25.166(3)Å b=5.0290(5)Å c=15.1590(16)Å
α=90° β=97.648(9)° γ=90°
N,N'-bis(2-pyridyl)biphenyl-4,4'-diamine 2,5-dihydroxy-1,4-benzoquinone (1/1)
C22H18N4,C6H4O4
Acta Crystallographica Section C (2002) 58, 12 o735-o738
a=14.8368(18)Å b=5.0801(6)Å c=16.0207(16)Å
α=90° β=114.106(11)° γ=90°
(S)-trans-cyclohexane-1,2-dicarboximide
C8H11NO2
Acta Crystallographica Section C (2002) 58, 11 o661-o662
a=5.9030(10)Å b=5.9030(10)Å c=45.164(4)Å
α=90° β=90° γ=90°
<i>p</i>-phenylenedimamine dihydrate
C6H8N2,2H2O
Acta Crystallographica Section C (2010) 66, 3 o128-o132
a=8.8599(8)Å b=15.0248(14)Å c=5.8952(4)Å
α=90.00° β=90.00° γ=90.00°
<i>p</i>-phenylenediamine
C6H8N2
Acta Crystallographica Section C (2010) 66, 3 o128-o132
a=8.3020(2)Å b=5.89700(10)Å c=22.7600(5)Å
α=90.00° β=93.579(2)° γ=90.00°
Benzene-1,2-diamine
C6H8N2
Acta Crystallographica Section C (2010) 66, 4 o198-o201
a=7.5330(17)Å b=7.8350(15)Å c=20.098(4)Å
α=90.00° β=90.00° γ=90.00°
DABCO monohydrate
C6H12N2,H2O
Acta Crystallographica Section C (2010) 66, 6 o270-o273
a=11.03798(15)Å b=11.03798(15)Å c=15.2660(2)Å
α=90.00° β=90.00° γ=120.00°
2,2',3,3',4,4',5,5',6,6'-decafluorodiphenylamine
C12HF10N
Acta Crystallographica Section C (2006) 62, 7 o419-o422
a=21.293(3)Å b=5.9659(8)Å c=4.4306(6)Å
α=90.00° β=101.702(11)° γ=90.00°
2,2',3,3',4,4',5,5',6,6'-Decafluorodiphenylamine--diphenylamine (1/1)
C12HF10N,C12H11N
Acta Crystallographica Section C (2006) 62, 7 o419-o422
a=21.417(3)Å b=5.7778(11)Å c=8.1895(14)Å
α=90.00° β=94.312(13)° γ=90.00°
Quinoxaline--2,3,5,6-tetrafluorobenzene-1,4-diol (1/1)
C8H6N2,C6H2F4O2
Acta Crystallographica Section C (2010) 66, 7 o356-o360
a=7.2094(5)Å b=7.4290(4)Å c=23.585(13)Å
α=90.00° β=90.00° γ=90.00°
Pyrazine--2,3,5,6-tetrafluorobenzene-1,4-diol (1/1)
C6H2F4O2,C4H4N2
Acta Crystallographica Section C (2010) 66, 7 o356-o360
a=3.6671(10)Å b=7.585(2)Å c=9.582(2)Å
α=88.14(2)° β=85.67(2)° γ=77.41(2)°
Phenazine--2,3,5,6-tetrafluorobenzene-1,4-diol (2/1)
2C12H8N2,C6H2F4O2
Acta Crystallographica Section C (2010) 66, 7 o356-o360
a=9.1482(5)Å b=11.0393(6)Å c=12.4185(8)Å
α=90.00° β=102.585(5)° γ=90.00°
N,N'-Bis(2-pyridyl)-1,2-diaminobenzene
C16H14N4
Acta Crystallographica Section C (2004) 60, 3 o215-o216
a=9.1835(6)Å b=7.8999(6)Å c=18.2023(13)Å
α=90.00° β=98.598(6)° γ=90.00°
2,4,6-trimethylbenzamide
C10H13NO
Acta Crystallographica Section C (2004) 60, 1 o41-o43
a=14.2587(9)Å b=8.5369(6)Å c=14.9245(10)Å
α=90.00° β=90.00° γ=90.00°
Benzamide--2,3,4,5,6-pentafluorobenzoic acid (2/1)
2C7H7NO,C7H1F5O2
Acta Crystallographica Section C (2006) 62, 8 o492-o494
a=15.3195(5)Å b=5.1799(3)Å c=24.6053(8)Å
α=90.000° β=90.784(3)° γ=90.000°
(+-)-<i>N,N'</i>-diethyl (1,2-diphenylethane-1,2-diyl)bis(2-thiooxamate)
C22H24N2O4S2
Acta Crystallographica Section C (2007) 63, 12 o693-o696
a=9.2414(4)Å b=21.7781(10)Å c=11.4322(6)Å
α=90.00° β=100.273(4)° γ=90.00°
(1<i>S</i>,3<i>S</i>,4<i>R</i>,7<i>S</i>)- 3-(4-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)- 1-hydroxymethyl-2,5-dioxabicyclo[2.2.1]heptan-7-ol
C11H13N5O4
Acta Crystallographica Section C (2008) 64, 8 o467-o470
a=7.1097(2)Å b=14.7372(5)Å c=22.0732(7)Å
α=90.00° β=90.00° γ=90.00°
Bis(di-2-pyridylamine-κ^2^<i>N</i>^2^,<i>N</i>^2^)silver(I) trifluoromethanesulfonate
C20H18AgN6,CF3O3S
Acta Crystallographica Section C (2010) 66, 11 m355-m357
a=15.1215(4)Å b=13.2206(3)Å c=11.9113(3)Å
α=90.00° β=107.527(3)° γ=90.00°
[μ-hydrogen bis(<i>N</i>,<i>N</i>-dioxidobutane-2,3-diimine)]tetrakis(1,10- phenanthroline)cobalt(III) trinitrate ethanol disolvate 1.87-hydrate
C56H45Co2N12O43,3NO3,2C2H6O,1.87H2O
Acta Crystallographica Section C (2010) 66, 9 m257-m262
a=19.0680(8)Å b=16.0170(5)Å c=20.0130(8)Å
α=90.00° β=104.353(4)° γ=90.00°
[<i>N</i>-hydroxy-<i>N</i>-oxidobutane-2,3-diimine(1-)- κ^2^<i>N</i>,<i>N</i>']bis(1,10-phenanthroline- κ^2^<i>N</i>,<i>N</i>)cobalt(III) dinitrate ethanol monosolvate 0.4-hydrate
C28H23CoN6O22,2NO3,C2H6O,0.40H2O
Acta Crystallographica Section C (2010) 66, 9 m257-m262
a=13.75870(10)Å b=11.97630(10)Å c=18.2055(2)Å
α=90.00° β=96.7440(10)° γ=90.00°
2,3,4,5,6-pentafluorophenol--phenazine (2/1)
2(C6HF5O),C12H8N2
Acta Crystallographica Section C (2011) 67, 9 o341-o345
a=4.9045(3)Å b=17.1342(10)Å c=12.6397(6)Å
α=90.00° β=90.931(5)° γ=90.00°
2,3,4,5,6-pentafluorophenol--phenazine (5/1)
5(C6HF5O),C12H8N2
Acta Crystallographica Section C (2011) 67, 9 o341-o345
a=16.1015(7)Å b=4.5223(2)Å c=27.4753(12)Å
α=90.00° β=97.315(4)° γ=90.00°
Rifampicin pentahydrate
C43H58N4O12,5(H2O)
Acta Crystallographica Section C (2012) 68, 5 o209-o212
a=13.8506(6)Å b=17.3867(8)Å c=19.7476(8)Å
α=90.00° β=90.00° γ=90.00°
Phenazine--naphthalene-1,5-diamine--water (1/1/2)
C12H8N2,C10H10N2,2(H2O)
Acta Crystallographica Section E (2009) 65, 12 o3177
a=13.0395(10)Å b=4.9266(2)Å c=15.7211(12)Å
α=90.00° β=112.508(9)° γ=90.00°
5-Amino-1-naphthol
C10H9NO
Acta Crystallographica Section E (2009) 65, 11 o2964
a=4.8607(2)Å b=12.3175(6)Å c=13.0565(5)Å
α=90.00° β=90.00° γ=90.00°
5-Methyl-3,6,7,8a-tetrahydro-2<i>H</i>- diimidazo[1,2-<i>c</i>:1',2'-<i>e</i>]pyrido[1,2-<i>a</i>][1,3,5]triazin-5-ium iodide
C12H16N5,I
Acta Crystallographica Section E (2010) 66, 6 o1486
a=7.6299(2)Å b=15.3939(4)Å c=11.4503(3)Å
α=90.00° β=92.204(2)° γ=90.00°
(Carbonato-κ^2^<i>O</i>,<i>O</i>)bis(di-2-pyridylamine- κ^2^<i>N</i>,<i>N</i>')cobalt(III) bromide
C21H18CoN6O3,Br
Acta Crystallographica Section E (2011) 67, 4 m414-m415
a=16.9605(3)Å b=7.43220(10)Å c=17.2590(4)Å
α=90.00° β=105.839(2)° γ=90.00°
<i>N</i>,<i>N</i>'-bis(pyridin-2-yl)benzene-1,4-diamine
C16H14N4
Acta Crystallographica Section E (2011) 67, 11 o3095
a=7.2534(2)Å b=20.8270(6)Å c=9.0681(3)Å
α=90.00° β=106.746(4)° γ=90.00°
(<i>R</i>,<i>R</i>)-1-Acetyl-1'-(2,4,6-trinitrophenyl)-2,2'-bipyrrolidine
C16H19N5O7
Acta Crystallographica Section E (2013) 69, 1 o144-o145
a=8.1989(5)Å b=10.4442(6)Å c=20.8877(13)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>,<i>N</i>'-Bis(pyridin-2-yl)benzene-1,4-diamine--quinoxaline (2/1)
2(C16H14N4),C8H6N2
Acta Crystallographica Section E (2011) 67, 12 o3254
a=11.8285(9)Å b=9.1223(7)Å c=14.7952(9)Å
α=90.00° β=93.698(5)° γ=90.00°
<i>N</i>,<i>N</i>'-Bis(pyridin-2-yl)benzene-1,4-diamine--naphthalene (2/1)
C10H8,2(C16H14N4)
Acta Crystallographica Section E (2011) 67, 12 o3300
a=9.22240(10)Å b=22.8371(2)Å c=8.87600(10)Å
α=90.00° β=117.936(2)° γ=90.00°
Rifampicin methanol trisolvate
C43H58N4O12,3(CH4O)
ACS infectious diseases (2019) 5, 10 1754-1763
a=10.1242(6)Å b=13.9473(6)Å c=35.3927(17)Å
α=90° β=90° γ=90°
Monoammonium glicyrrhizinate 3.0 DMF 6.53 water solvate
C42H61O16,3.00(C3H7NO),6.53(H2O),H4N
Crystal Growth & Design (2014) 14, 11 5871
a=10.2250(3)Å b=11.4024(3)Å c=53.2811(14)Å
α=90° β=90° γ=90°
(E)-Ethyl 3-(4,6-dimethyl-3- oxoisoxazolo[3,4-b]pyridin-1(3H)-yl)but-2-enoate (2b)
C14H16N2O4
The Journal of organic chemistry (2017) 82, 18 9737-9743
a=4.07910(10)Å b=8.7997(2)Å c=19.3763(4)Å
α=90° β=92.115(2)° γ=90°
(Z)-Ethyl 3-(4,6-dimethyl-3-oxoisoxazolo[3,4-b]pyridin-1(3H)-yl)acrylate
C13H14N2O4
The Journal of organic chemistry (2017) 82, 18 9737-9743
a=12.5735(6)Å b=6.9794(3)Å c=15.5620(8)Å
α=90° β=107.943(5)° γ=90°
(E)-1-(3-Oxobut-1-enyl)isoxazolo[3,4-b]quinolin-3(1H)-one
C14H10N2O3
The Journal of organic chemistry (2017) 82, 18 9737-9743
a=3.83581(5)Å b=9.67555(10)Å c=31.0045(4)Å
α=90° β=90.1572(11)° γ=90°
Ethyl 2-(3-ethoxy-3-oxopropanamido)-4,6-dimethylnicotinate
C15H20N2O5
The Journal of organic chemistry (2017) 82, 18 9737-9743
a=10.9426(6)Å b=17.6300(11)Å c=8.9922(5)Å
α=90° β=112.155(5)° γ=90°
(2E,3E)-Diethyl 2-(((E)-3-ethoxy-3-oxoprop-1-enyloxy)methylene)-3-((3-(ethoxycarbonyl)quinolin-2-ylamino)methylene)succinate
C27H30N2O9
The Journal of organic chemistry (2017) 82, 18 9737-9743
a=8.8727(6)Å b=11.1374(7)Å c=15.4529(9)Å
α=100.611(5)° β=95.091(5)° γ=112.613(6)°
(2E,3E)-Diethyl 2-(((E)-3-ethoxy-3-oxoprop-1-enyloxy)methylene)-3-((3-(ethoxycarbonyl)-4,6-dimethylpyridin-2-ylamino)methylene)succinate
C25H32N2O9
The Journal of organic chemistry (2017) 82, 18 9737-9743
a=8.2258(4)Å b=11.9963(6)Å c=14.8642(8)Å
α=79.378(4)° β=77.597(4)° γ=76.203(4)°
(R)-(-)-5,11-dimethyldibenzo[b,f][1,5]diazocine-6,12(5H,11H)-dithione
C16H14N2S2
Journal of Organic Chemistry (2008) 73, 4859-4864
a=7.9798(5)Å b=10.2973(9)Å c=17.5711(14)Å
α=90.00° β=90.00° γ=90.00°
5,11-dimethyldibenzo[b,f][1,5]diazocine-6,12(5H,11H)-dithione bis-pentafluorophenol co-crystal
C16H14N2S2,2(c6HF5O)
Journal of Organic Chemistry (2008) 73, 4859-4864
a=21.417(3)Å b=7.5864(8)Å c=17.247(2)Å
α=90.00° β=95.493(12)° γ=90.00°
4(C10H15AgO4S),2(C16H14N2S2),2(H2O),2(CH2Cl2)
4(C10H15AgO4S),2(C16H14N2S2),2(H2O),2(CH2Cl2)
Journal of Organic Chemistry (2008) 73, 4859-4864
a=10.9118(7)Å b=13.9513(9)Å c=16.0627(10)Å
α=103.793(5)° β=108.602(6)° γ=103.178(5)°
5,11-dimethyldibenzo[b,f][1,5]diazocine-6,12(5H,11H)-dithione
C16H14N2S2
Journal of Organic Chemistry (2008) 73, 4859-4864
a=13.9899(8)Å b=17.6632(9)Å c=12.3039(6)Å
α=90.00° β=103.639(5)° γ=90.00°
5,11-dimethyldibenzo[b,f][1,5]diazocine-6,12(5H,11H)-dithione toluene 2:1 solvate
2(C16H14N2S2),C7H8
Journal of Organic Chemistry (2008) 73, 4859-4864
a=8.5694(8)Å b=9.811(2)Å c=11.707(2)Å
α=107.36(2)° β=95.120(10)° γ=101.21(2)°
(5S,6S)-5,6-Diphenyl-2,3- piperazinedione tetrahydrofuran solvate (1:1)
C16H14N2O2,C4H8O1
The Journal of Organic Chemistry (2008) 73, 7 2852-2861
a=12.405(2)Å b=6.9058(10)Å c=11.0030(12)Å
α=90.00° β=90.00° γ=90.00°
(S)-1,4-Dimethyl-5-benzyl-2,3-piperazinedithone
C13H16N2S2
The Journal of Organic Chemistry (2008) 73, 7 2852-2861
a=7.2071(18)Å b=15.029(3)Å c=13.526(4)Å
α=90.00° β=104.71(2)° γ=90.00°
(9R,10R)-2,3-Decahydrobenzopyrazinodione
C8H12N2O2
The Journal of Organic Chemistry (2008) 73, 7 2852-2861
a=6.6090(3)Å b=6.6090(3)Å c=18.8339(15)Å
α=90.00° β=90.00° γ=90.00°
(R)-5-Methyl-2,3-piperazynodione
C5H8N2O2
The Journal of Organic Chemistry (2008) 73, 7 2852-2861
a=6.98100(10)Å b=6.98100(10)Å c=24.2018(7)Å
α=90.00° β=90.00° γ=90.00°
(R)-1,4,5-Trimethyl-2,3-piperazynodione
C7H12N2O2
The Journal of Organic Chemistry (2008) 73, 7 2852-2861
a=7.8934(2)Å b=9.0440(2)Å c=11.2187(3)Å
α=90.00° β=90.00° γ=90.00°
148C
C7H12N2S2
The Journal of Organic Chemistry (2008) 73, 7 2852-2861
a=6.4030(12)Å b=11.526(2)Å c=12.735(3)Å
α=90.00° β=90.00° γ=90.00°
(5S,6S)-5,6-Diphenyl-2,3- piperazinedione bis(pentafluorobenzoic acid) monohydrate
C16H14N2O2,2(C7H1F5O2),H2O
The Journal of Organic Chemistry (2008) 73, 7 2852-2861
a=14.4997(15)Å b=5.9482(7)Å c=16.7914(17)Å
α=90.00° β=94.631(9)° γ=90.00°
(5S,6S)-1,4-Dimethyl-5,6-diphenyl-2,3-piperazinedione
C18H18N2O2
The Journal of Organic Chemistry (2008) 73, 7 2852-2861
a=23.6192(10)Å b=6.7822(3)Å c=16.8873(6)Å
α=90.00° β=119.234(4)° γ=90.00°
(S)-1,4-Dimethyl-5-benzyl-2,3-piperazinedithone
C13H16N2S2
The Journal of Organic Chemistry (2008) 73, 7 2852-2861
a=10.2156(11)Å b=14.1494(12)Å c=9.4788(8)Å
α=90.00° β=90.00° γ=90.00°
(R)-dithiodianthranilide
C14H10N2S2
Journal of Organic Chemistry (2004) 69, 1248-1255
a=6.656(1)Å b=14.038(3)Å c=40.714(8)Å
α=90.00° β=90.00° γ=90.00°
C14H9N2S21,C6H15N21,2(C6H14N2)
C14H9N2S21,C6H15N21,2(C6H14N2)
Journal of Organic Chemistry (2004) 69, 1248-1255
a=9.6070(10)Å b=12.8255(15)Å c=14.2170(12)Å
α=90.00° β=102.919(8)° γ=90.00°
Dianthranilide
C14H10N2O2
Journal of Organic Chemistry (2004) 69, 1248-1255
a=8.6349(17)Å b=11.2312(19)Å c=12.402(2)Å
α=97.534(15)° β=96.796(16)° γ=93.056(15)°
C34H34N2O8
C34H34N2O8
Journal of Organic Chemistry (2004) 69, 1248-1255
a=10.737(2)Å b=14.931(3)Å c=18.911(4)Å
α=90.00° β=90.00° γ=90.00°
Dithiodiantranilide
C14H10N2S2
Journal of Organic Chemistry (2004) 69, 1248-1255
a=7.669(2)Å b=9.014(2)Å c=9.620(2)Å
α=83.99(2)° β=89.72(2)° γ=68.74(2)°
Dianthranilide DMSO solvate
2(C14H10N2O2),C2H6OS
Journal of Organic Chemistry (2004) 69, 1248-1255
a=17.3970(10)Å b=8.5828(5)Å c=18.7108(11)Å
α=90.00° β=103.073(5)° γ=90.00°
(S)-(+)-dianthranilide DMSO 1:1 solvate
C14H10N2O2,C2H6OS
Journal of Organic Chemistry (2004) 69, 1248-1255
a=8.7490(10)Å b=9.7710(10)Å c=18.104(2)Å
α=90.00° β=90.00° γ=90.00°
7-benzyl-6,7-dihydro-5H-imidazo[2,1-c][1,2,4]thiadiazol-3-thione
C11H11N3S2
Journal of Organic Chemistry (2003) 68, 4791-4796
a=6.6652(5)Å b=8.1833(8)Å c=11.2460(8)Å
α=83.311(7)° β=77.601(6)° γ=69.863(8)°
7,8-dihydroimidazo[1,2-c][1,3,5]thiadiazine-2,4(6H)-dithione
C5H5N3S3
Journal of Organic Chemistry (2003) 68, 4791-4796
a=22.7501(13)Å b=6.1929(4)Å c=15.6134(9)Å
α=90.00° β=132.541(5)° γ=90.00°
6,7-dihydro-3-spiro(4-methylcyclohexyl)-5H-imidazo[2,1-c][1,2,4]oxadiazole
C10H17N3O
Journal of Organic Chemistry (2003) 68, 4791-4796
a=10.6922(14)Å b=9.8340(13)Å c=10.9612(14)Å
α=90.00° β=115.541(13)° γ=90.00°
3-phenyl-2-phenylimino-8-(n-phenylthiocarbamoyl) -2,6,7,8-tetrahydroimidazo[1,2-a][1,3,5]triazin -4(3H)-thione
C24H20N6S2
Journal of Organic Chemistry (2003) 68, 4791-4796
a=9.9784(4)Å b=16.5446(6)Å c=13.1448(6)Å
α=90.00° β=91.663(4)° γ=90.00°
7-benzyl-6,7-dihydro-5H-imidazo[2,1-c][1,2,4]thiadiazol-3-thione
C11H11N3S2
Journal of Organic Chemistry (2003) 68, 4791-4796
a=6.6652(5)Å b=8.1833(8)Å c=11.2460(8)Å
α=83.311(7)° β=77.601(6)° γ=69.863(8)°
7,8-dihydroimidazo[1,2-c][1,3,5]thiadiazine-2,4(6H)-dithione
C5H5N3S3
Journal of Organic Chemistry (2003) 68, 4791-4796
a=22.7501(13)Å b=6.1929(4)Å c=15.6134(9)Å
α=90.00° β=132.541(5)° γ=90.00°
6,7-dihydro-3-spiro(4-methylcyclohexyl)-5H-imidazo[2,1-c][1,2,4]oxadiazole
C10H17N3O
Journal of Organic Chemistry (2003) 68, 4791-4796
a=10.6922(14)Å b=9.8340(13)Å c=10.9612(14)Å
α=90.00° β=115.541(13)° γ=90.00°
3-phenyl-2-phenylimino-8-(n-phenylthiocarbamoyl) -2,6,7,8-tetrahydroimidazo[1,2-a][1,3,5]triazin -4(3H)-thione
C24H20N6S2
Journal of Organic Chemistry (2003) 68, 4791-4796
a=9.9784(4)Å b=16.5446(6)Å c=13.1448(6)Å
α=90.00° β=91.663(4)° γ=90.00°
7-acetyl-6,7-dihydro-5H-imidazo[2,1-c][1,2,4]thiadiazol-3-thione
C9H8N6S5
Journal of Organic Chemistry (2003) 68, 4791-4796
a=6.2662(3)Å b=13.0714(7)Å c=17.4538(9)Å
α=90.00° β=90.00° γ=90.00°
C56H98O351.08H2O
C56H98O351.08H2O
Journal of the American Chemical Society (2001) 123, 3919-3926
a=13.3280(13)Å b=17.4100(17)Å c=29.760(3)Å
α=90.000(9)° β=90.000(9)° γ=90.000(9)°
C56H98O3514.7H2O
C56H98O3514.7H2O
Journal of the American Chemical Society (2001) 123, 3919-3926
a=13.976(7)Å b=20.763(7)Å c=28.807(8)Å
α=90.00000° β=90.00000° γ=90.00000°
Cholic acid propiophenone clathrate
C24H40O5.C9H10O1
Journal of the American Chemical Society (1998) 120, 7353-7354
a=16.752(3)Å b=7.910(2)Å c=12.222(2)Å
α=90.00° β=114.28(3)° γ=90.00°
Cholic acid 4-fluoropropiophenone clathrate
C24H40O5.C9H9O1F1
Journal of the American Chemical Society (1998) 120, 7353-7354
a=16.668(3)Å b=8.150(4)Å c=12.064(2)Å
α=90.00° β=113.24(2)° γ=90.00°
C60H46N22Ni
C60H46N22Ni
Inorganic Chemistry (2007) 46, 3946-3955
a=8.805(2)Å b=12.308(2)Å c=13.052(3)Å
α=78.04(3)° β=86.39(3)° γ=76.43(3)°
C12H38Cl4Cu2N6O4
C12H38Cl4Cu2N6O4
Inorganic Chemistry (2007) 46, 3946-3955
a=12.4550(14)Å b=15.6884(17)Å c=6.2507(7)Å
α=90.00° β=90.806(2)° γ=90.00°
C12H32Cl2CuN6O
C12H32Cl2CuN6O
Inorganic Chemistry (2007) 46, 3946-3955
a=13.1690(12)Å b=9.3466(9)Å c=15.2323(14)Å
α=90.00° β=97.627(2)° γ=90.00°
C36H38N14Ni
C36H38N14Ni
Inorganic Chemistry (2007) 46, 3946-3955
a=15.349(3)Å b=15.598(3)Å c=16.174(3)Å
α=75.769(4)° β=75.452(5)° γ=85.635(4)°
Monoammonium beta-glycyrrhizate complex with p-aminobenzoic acid 3.53 methanol 1.82 water solvate
C42H61O16,C7H7NO2,3.53(CH4O),H4N,1.82(H2O)
Crystal Growth & Design (2012) 12, 4 2133
a=10.4464(2)Å b=11.2468(2)Å c=51.0762(5)Å
α=90.00° β=90.00° γ=90.00°
Glycyrrhizic acid 4.26 propionic acid 3.94 water solvate
C42H62O16,4.26(C3H6O2),3.94(H2O)
Crystal Growth & Design (2012) 12, 4 2133
a=10.6054(2)Å b=11.3456(2)Å c=52.5014(5)Å
α=90.00° β=90.00° γ=90.00°
Monoammonium beta-glycyrrhizate 3.53 methanol 1.82 water solvate
C42H61O16,6.25(CH4O),H4N,2.04(H2O)
Crystal Growth & Design (2012) 12, 4 2133
a=10.3718(2)Å b=11.2995(2)Å c=50.3536(6)Å
α=90.00° β=90.00° γ=90.00°
Monoammonium glicyrrhizinate 4.0 propionic acid 3.0 water solvate
C42H61O16,4.00(C3H6O2),3.0(H2O),H4N
Crystal Growth & Design (2013) 13, 3 1301
a=10.6684(2)Å b=11.12450(10)Å c=51.3881(7)Å
α=90.00° β=90.00° γ=90.00°
Monopotassium glicyrrhizinate 5.66 acetic acid 2.02 water solvate
C42H61O16,K,5.64(C2H4O2),2.08(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=10.1563(3)Å b=11.1999(5)Å c=53.6150(15)Å
α=90.00° β=90.00° γ=90.00°
Monocaesium glicyrrhizinate 3.79 propionic acid 3.21 water solvate
C42H61O16,Cs,3.79(C3H6O2),3.21(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=10.6730(2)Å b=11.1804(2)Å c=51.5673(12)Å
α=90.00° β=90.00° γ=90.00°
Diammonium glicyrrhizinate 3.0 DMF 2.0 water solvate
C42H60O16,2.00(NH4),3.00(C3H7NO),2.0(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=9.8550(4)Å b=11.2823(3)Å c=52.659(3)Å
α=90.00° β=90.00° γ=90.00°
Dipotassium glicyrrhizinate 3.0 DMF 2.0 water solvate
C42H60O16,K2,3.00(C3H7NO),2.0(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=9.84050(10)Å b=11.25200(10)Å c=52.2345(2)Å
α=90.00° β=90.00° γ=90.00°
Dicaesium glicyrrhizinate 3.00 DMF 3.40 water solvate
C42H60O16,Cs2,3.00(C3H7NO),3.40(H2O)
Crystal Growth & Design (2013) 13, 3 1301
a=10.28540(10)Å b=11.48450(10)Å c=51.8388(6)Å
α=90.00° β=90.00° γ=90.00°
C27H22CoN7O4,NO3
C27H22CoN7O4,NO3
Inorganic Chemistry (2013) 52, 6559-6569
a=10.2990(6)Å b=11.3482(7)Å c=12.5241(7)Å
α=106.519(5)° β=107.472(5)° γ=91.459(5)°